Should You Invest In Hikma Pharmaceuticals PLC?

Get the facts about trading Hikma Pharmaceuticals PLC before you start. Discuss investment strategies, review market research, and get real-time updates

24,203 Hikma Pharmaceuticals PLC positions opened on eToro

Sell HIK.L
HIK.LHikma Pharmaceuticals PLC
1638.7689.92 ( 5.81%)
141.82 (2.45%)
2371.82 (5.19%)
267.80 (3.41%)
39.52 (1.89%)

Hikma Pharmaceuticals plc was founded in 1978 and is based in London, England. The company develops, manufactures and markets quality branded and non-branded generic medicines. Hikma Pharmaceuticals operates the first US FDA inspected pharmaceutical manufacturing facility in the Middle East. The company has 29 manufacturing plants in 11 countries and 7 R&D centres. In 2017, Hikma Pharmaceuticals reported $1,936 million in revenue. Learn more about this instrument and buy HIK.L stocks.

Buy HIK.L Now
Sell HIK.L Now

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.

Volatility means opportunity! Watch price changes reflect directly onto your portfolio

Start trading within minutes - no physical purcase delays

Benefit from falling prices as well as rising prices. Buy or sell instantly

Start Trading
Zero commission means that no broker fee will be charged when opening or closing the position and does not apply to short or leveraged positions. Other fees apply including FX fees on non-USD deposits and withdrawals. Your capital is at risk. For more information, click it